查询词典 patents
- 与 patents 相关的网络例句 [注:此内容来源于网络,仅供参考]
-
As of 2006, long has been unlicensed mineral wool acoustic board more than 40 patents, including technology with higher levels of seven patents, mineral wool acoustic board in China to lead the industry to flourish.
截止2006年,龙牌矿棉吸声板已获专利授权四十余项,其中技术含量较高的发明专利七项,引领中国矿棉吸声板行业蓬勃发展。
-
So strong is the company's development power that it has obtained 57 national patents including 8 patents of national gold prize and silver prize. Jialin is the legal manufacture for the two patents: water-guard (also named cleverness corer, patent No. ZL94226092.9) and top open type seal corer patent No.
公司开发力量雄厚,目前已获得国家专利57项,并有8项专利获国家专利金奖、银奖,为"冷热饮水机的进水装置"专利(专利号为:ZL94226092.9)和"顶启式密封瓶盖"专利(专利号为:ZL94226093.7)的权利人。
-
We have acquired 24 national patents yet, another 10 patents are on the docket.
目前,本车已经获得24项国家专利,并有另外16项专利正在审理中。
-
Triangle pushes forward the brand strategy which highlights science, quality and market, and the business conception of "people oriented". Triangle tires have successively passed the authoritative certifications of DOT, ECE and CCC, tire major performance index has reached international advanced level. Triangle has more then 139 patents, 26 of them are invention patents. The project of "Jumbo OTR tire manufacturing technology and equipments development" was awarded as national scientific development first-class prize, which is the first greatest honor for tire enterprise across China. Triangle brand became the first tire enterprise in China that got the certification of "China far-famed trademark" and "China famous brand product".
集团推行以科技、质量、市场为核心的品牌战略与"以人为本"的经营理念,"三角"牌轮胎先后通过了DOT、ECE和CCC等国内外权威认证,主要性能指标达到国际先进水平,并拥有139项国家专利技术,其中发明专利26项;公司"巨型工程子午胎成套生产技术与设备开发"项目获国家科技进步一等奖,为国内轮胎行业的最高科技奖项;"三角"成为国内行业首个"中国驰名商标"与首批"中国名牌产品"。
-
Factors that could affect results include the ability to market and sell products; changes in relationships with strategic partners and reliance on strategic partners for the performance of critical activities under collaborative arrangements; failure of distributors or other customers to meet purchase forecasts or minimum purchase requirements for our products; impact of competitors, competing products and technology changes; ability to develop, commercialize and market new products; market acceptance of oral fluid testing or other new products or technology; changes in market acceptance based on product performance; continued bulk purchases by customers, including governmental agencies, and the ability to fully deploy those purchases in a timely manner; ability to fund research and development and other products and operations; ability to obtain and maintain new or existing product distribution channels; reliance on sole supply sources for critical product components; availability of related products produced by third parties; ability to obtain, and timing and cost of obtaining, necessary regulatory approval for new products or new indications or applications for existing products; ability to comply with applicable regulatory requirements; history of losses and ability to achieve sustained profitability; volatility of our stock price; uncertainty relating to patent protection and potential patent infringement claims; uncertainty and costs of litigation relating to patents and other intellectual property; availability of licenses to patents or other technology; ability to enter into international manufacturing agreements; obstacles to international marketing and manufacturing of products; ability to sell products internationally; loss or impairment of sources of capital; ability to meet financial covenants in agreements with financial institutions; ability to retain qualified personnel; exposure to product liability, patent infringement, and other types of litigation; changes in international, federal or state laws and regulations; customer consolidations and inventory practices; equipment failures and ability to obtain needed raw materials and components; the impact of terrorist attacks and civil unrest; ability to complete consolidation or restructuring activities; ability to identify, complete and realize the full benefits of potential acquisitions; and general political, business and economic conditions.
可能影响结果的因素包括营销以及出售产品的能力;与战略合作伙伴关系的变化以及根据合作协议对战略合作伙伴执行关键活动的依赖;经销商或者其他顾客未达到我方产品的采购预测或者最低采购要求;竞争对手、竞争产品以及技术变化的影响;新产品开发、商业化以及营销的能力;市场对唾液检测、其他新产品或者技术的接收程度、基于产品效果所造成的市场接收的变化;顾客、包括政府机构的持续大宗采购以及按时完成采购的能力;资助研究、开发以及其他产品和活动的能力;获得并维持新的或者现有的产品经销渠道的能力;关键产品部件对单一供应源的依赖;第三方生产的相关产品的供应情况;新产品或者现有产品的新疗效获得必要的管制批准的能力、时间以及费用;遵守适用的管制要求的能力;亏损的历史以及实现可持续盈利的能力;股票价格的波动;与专利保护和潜在的专利侵权诉讼有关的不确定性;与专利以及其他知识产权有关的不确定性以及诉讼费用;专利以及其他技术授权的提供情况;签订国际性制造协议的能力;产品进行国际营销以及制造的障碍;国际性销售产品的能力;资本来源的损失或者减少;履行与财务机构之间协议的能力;获得合格人员的能力;产品责任、专利侵权以及其他诉讼的风险;国际、联邦或者州的法律、法规的变化;顾客合并以及存货实践;设备故障以及获得所需原材料和部件的能力;恐怖主义袭击以及内乱的影响;完成合并或者重组活动的能力;识别、完成以及实现潜在收购的全部利益的能力;一般性政治、商业、经济形势等。
-
Still, business method patents were relatively rare until the 1998 State Street decision, after which "a flood of business method patents came through the door," says Jon Dudas, a former director of the Patent Office who is now a partner with Foley Lardner.
然而,商业方法专利在过去相对较少,直到1998年道富银行和信托公司对签记金融集团案判决下达,之后"商业方法专利如洪水般破门而出,"杜达斯说,他是专利局的前任董事,现在是佛雷劳德的合伙人。
-
San Jose led the list with 3,867 utility patents filed in 2005, and number two was Sunnyvale, at 1,881 utility patents.
圣何塞领导名单3867实用专利申请在2005年,和排名第二的是雅虎,在1881年实用专利。
-
In order to support innovative design, by analyzing existing problems in current methods to acquire heterogeneous product patents, an association-extension method was proposed. Particularly it was helpful in effectively acquiring associational heterogeneous product patents.
为辅助产品创新设计,分析了可能用于获取异类产品专利的现有方法存在的问题,提出了一种特别有利于高效获取关联异类产品专利的新方法―关联拓展法。
-
The National Cancer Institute, the National Institutes of Health, and Corixa supported this study. Corixa employs one of the authors and has various financial arrangements with several other authors. Some of the authors report potential financial conflicts of interest with GlaxoSmithKline. Two authors receive royalties from patents they jointly hold on anti-CD20 radioimmunotherapy for lymphoma, and they have been expert witnesses in defending these patents.
国家癌症机构、国家卫生研究院及Corixa赞助这项试验;Corixa雇用其中一位研究人员,而且许多其他研究人员接受该公司的资金赞助;某些研究人员表示与葛兰素药厂有潜在资金上的冲突;两位研究人员接受来自病患的专利权费,这两位共同拥有抗CD20放射线免疫疗法治疗淋巴瘤的专利,且他们一直是保护这些病患的专家证人。
-
dwpi patent database of thomson group was chosen, led signal display technology patents between january 1, 1965 to december 31, 2008 were collected and the associated patent database was established. derwent innovation index patent analysis system was chosen, these led signal display technology patents were analyzed deeply from the total amount of patent applications, key led patents and key patent holders respectively. the present patent status of abroad and china's were compared. the patent strategy of developing our nation's led signal display technology was also discussed.
选择thomson集团的dwpi英文专利数据库,采集1965年1月1日到2008年12月31日期间的led信号显示技术专利文献,建立英文专利数据库;再选择derwent innovation index专利分析系统,分别从专利申请总量、重点专利技术和重点专利持有人等方面,对led信号显示技术专利进行深入的分析,并对比分析国内外led信号显示技术专利的现状,提出发展我国led信号显示技术的专利策略。
- 推荐网络例句
-
Neither the killing of Mr Zarqawi nor any breakthrough on the political front will stop the insurgency and the fratricidal murders in their tracks.
在对危险的南部地区访问时,他斥责什叶派民兵领导人对中央集权的挑衅行为。
-
In fact,I've got him on the satellite mobile right now.
实际上 我们已接通卫星可视电话了
-
The enrich the peopling of Deng Xiaoping of century great person thought, it is the main component in system of theory of Deng Xiaoping economy, it is a when our country economy builds basic task important facet.
世纪伟人邓小平的富民思想,是邓小平经济理论体系中的重要组成部分,是我国经济建设根本任务的一个重要方面。